Ann: Trading Halt, page-90

and on that note:

Coronavirus R&D Gets $3.1 Billion in Emergency FundingMarch 5, 2020U.S. lawmakers passed a $8.3 billion emergency supplemental bill to fund the federal coronavirus response that includes $3.1 billion for developing diagnostics, vaccines and other medical countermeasures.The bill allocated $61 million to the FDA to “facilitate the development and review, both pre-market and post-market, of medical countermeasures, devices, therapies, and vaccines.
”https://www.fdanews.com/articles/196133-coronavirus-rd-gets-31-billion-in-emergency-funding